Ultralife Corporation

Total Valuation

Ultralife Corporation carries a market capitalization of 118.43M, placing it among publicly traded companies globally. Its enterprise value stands at 147.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Ultralife Corporation currently has 16.66M shares outstanding.

Valuation Ratios

Ultralife Corporation trades at a trailing price-to-earnings ratio of 112.77. The price-to-sales ratio is 0.58, and the price-to-book ratio stands at -2.81.

Enterprise Valuation

On an enterprise value basis, Ultralife Corporation trades at an EV/EBITDA multiple of 18.13 and an EV/FCF ratio of 9.01. The EV/Sales ratio of 0.78 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 55.31 provides insight into valuation relative to core operating earnings.

Financial Position

Ultralife Corporation maintains a current ratio of 2.56, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 36.71, indicating elevated leverage, while an interest coverage ratio of 2.15 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Ultralife Corporation has paid -3.21M in income taxes, reflecting an effective tax rate of 21.83.

Stock Price Statistics

Ultralife Corporation's stock has declined approximately -1.93103% over the past 52 weeks. The 50-day moving average sits at 6.83, while the 200-day moving average is 6.45.

Income Statement

Over the trailing twelve months, Ultralife Corporation generated 187.86M in revenue and converted that into -8.21M in net income, yielding earnings per share of -0.50. EBITDA reached 8.13M, while operating income came in at 2.67M.

Balance Sheet

Ultralife Corporation holds 8.89M in cash and equivalents against 47.63M in total debt, resulting in a net debt position of 38.74M. Total book value stands at -38.68M, with working capital of 67.05M providing operational flexibility.

Cash Flow

Ultralife Corporation produced 9.88M in operating cash flow over the past twelve months. After subtracting -3.75M in capital expenditures, free cash flow totaled 6.13M - equivalent to 0.37 per share.

Margins

Ultralife Corporation operates with a gross margin of 23.10, reflecting its pricing power and cost economics. The operating margin of 1.42 and net profit margin of -4.37 provide insight into operational efficiency.

Dividends & Yields

Scores

Ultralife Corporation posts an Altman Z-Score of 2.05, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.